Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03221296
Other study ID # 17-5055
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 27, 2017
Est. completion date August 23, 2018

Study information

Verified date October 2018
Source University Health Network, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A feasibility study of a vestibular rehabilitation program in a sample of cognitively impaired clinical patients to guide future trials.


Description:

Read more »
Read more »

Study Design


Intervention

Behavioral:
Vestibular Training (Intervention Group)
Exercises three times daily, for up to approximately 20 minutes. Changes in functional status and physical status shall be measured at study onset and follow up.

Locations

Country Name City State
Canada Toronto Western Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of falls/near fall experiences through the Falls Video Analysis Questionnaire (FVAQ) Measured by comparing the test score change from baseline to follow up at 3 months and again at 6 months to determine if the therapy worked 3 months and again 6 months after baseline
Secondary Change in levels of dizziness through the Dizziness Handicap Inventory (DHI) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in perceived level of confidence through the Activities Specific Balance Confidence Scale (ABC) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in quality of life through The Geriatric Depression Scale (GDS) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Cognitive status through the Montreal Cognitive Assessment (MoCA) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in physical functioning through the head impulse test (HIT) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Number of patients who can successfully complete Head Impulse Test (HIT) Shall be measured by proportion of participants completing test (did not need to stop for any reason) 3 months
Secondary Number of patients who can successfully complete Head Shake Test (HST) Shall be measured by proportion of participants completing test (did not need to stop for any reason) 3 months
Secondary Number of patients who can successfully complete Dynamic Gait Index (DGI) Shall be measured by proportion of participants completing test (did not need to stop for any reason) 3 months
Secondary Number of patients who can successfully complete the test of dynamic visual acuity (DVA) Shall be measured by proportion of participants completing test (did not need to stop for any reason) 3 months
Secondary Number of patients who can successfully complete the modified clinical test of sensory interaction on balance (mCTSIB) Shall be measured by proportion of participants completing test (did not need to stop for any reason) 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Dizziness Handicap Inventory (DHI) Shall be measured by percentage of test items completed 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Montreal Cognitive Assessment (MoCA) Shall be measured by percentage of test items completed 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Quality of Life in Alzheimer's Disease (QOL-AD) Shall be measured by percentage of test items completed 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the World Health Organization Quality of Life - BREF (WHOQOL-BREF) Shall be measured by percentage of test items completed 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Activities Specific Balance Confidence scale (ABC) Shall be measured by percentage of test items completed 3 months
Secondary Completeness of questionnaires and which questions were: skipped, missed or difficult to understand for the Geriatric Depression Scale (GDS) Shall be measured by percentage of test items completed 3 months
Secondary Number of patients who successfully adhered to the vestibular rehabilitation program through the Problematic Experiences of Therapy scale (PETs) filled out by both, or either one of, the patient or caregiver 3 months
Secondary Attrition Rate Will be measured as the percentage of those who reached follow-up compared to those who completed baseline 3 months
Secondary Number of patients willing to participate Determined by the proportion of patients saying yes out of those contacted 3 months
Secondary Change in quality of life through The World Health Organization Quality of Life - BREF (WHOQOL-BREF) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in quality of life through The Quality of Life in Alzheimer's Disease (QOL-AD) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in physical functioning through the head shake test (HST) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in physical functioning through the dynamic visual acuity (DVA) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in physical functioning through the modified clinical test of sensory interaction on balance (mCTSIB) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
Secondary Change in physical functioning through the dynamic gait index (DGI) Measured by comparing the test score change from baseline to follow up at 3 months 3 months
See also
  Status Clinical Trial Phase
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT04109963 - Trial of Remote Ischemic Pre-conditioning in Vascular Cognitive Impairment Phase 2
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Not yet recruiting NCT06416371 - Retinal Vessel Leakage in Cerebral Small Vessel Disease
Completed NCT01761227 - Efficacy and Safety of Fufangdanshen Tablets in Mild to Moderate Vascular Dementia Phase 2
Active, not recruiting NCT01208675 - The Swedish BioFINDER Study
Completed NCT00165763 - Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia Phase 4
Completed NCT00621647 - Seroquel- Agitation Associated With Dementia Phase 3
Recruiting NCT04095962 - Effects of a Multicomponent Exercise Intervention on Physical and Cognitive Function of Older Adults With Dementia N/A
Recruiting NCT03275363 - The University of Hong Kong Neurocognitive Disorder Cohort N/A
Active, not recruiting NCT03804229 - Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia Phase 3
Enrolling by invitation NCT03724136 - Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study N/A
Completed NCT02453932 - Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia Phase 3
Completed NCT00947531 - A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia Phase 4
Not yet recruiting NCT03702543 - Managing Vascular Dementia Risk Factors With SymTrend Phase 1
Enrolling by invitation NCT02147652 - Personalized Music Therapy and Agitation in Dementia N/A
Recruiting NCT04114994 - Longitudinal Cognitive Assessment by BoCA
Recruiting NCT06034509 - Cognitive and Vascular Functioning Following TBI
Recruiting NCT05921266 - Urolithin A Supplementation in Middle-aged Adults With Obesity N/A
Completed NCT01465360 - Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center N/A